“SGLT2 Inhibitors in Elderly and Frail CKM Patients Consistent benefit across age and frailty, with no excess hypoglycaemia” (2026) Diabzen, 4(15), pp. 28–29. Available at: https://thediabzen.com/index.php/d/article/view/57 (Accessed: 28 July 2026).